Investigation Overview
An investigation on behalf of current investors of CuraGen Corporation (Public, NASDAQ:CRGN) over potential breaches of fiduciary duty and other violations of state law by the Board of Directors of CuraGen was announced. The investigation by a law firm focuses on potential breaches of fiduciary duty and other violations of state law by the Board of Directors of CuraGen Corporation (...
You must register (for free) or login to view the entire investigation.